BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  ASCO Preview: Immutep, InxMed and Faron Release New Clinical Findings

  The ASCO Annual Meeting being held in June 3 to 7 will introduce hundreds of posters, abstracts and presentations of cancer studies, preclinical and clinical. BioSpace looks at three presenters.

  May 31, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  TG Will Have to Wait Till December for MS Drug Decision Date

  The FDA has decided to extend the Prescription Drug User Fee Act (PDUFA) review date for TG Therapeutics’s ublituximab until December 2022.

  May 31, 2022

   · 

  2 min read

   · 

  Jazmine Colatriano, M.S.
• 

  Drug Development

  Once Hopeful Prostate Cancer Drug Fails Phase II Test

  RhoVac AB announced Tuesday that its candidate therapeutic for prostate cancer failed to meet targets in a Phase IIb study.

  May 31, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  GSK Bolsters Vaccines Business with $3.3B Affinivax Buy

  GSK announced that it is acquiring Affinivax for up to $3.3 billion to gain its novel class of developmental vaccines and its MAPS technology.

  May 31, 2022

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Eledon Asset Shows Optimistic Biomarker Activity in ALS Trial

  Eledon Pharmaceuticals announced positive topline results from its Phase IIa clinical trial evaluating tegoprubart in patients with amyotrophic lateral sclerosis (ALS).

  May 31, 2022

   · 

  2 min read

   · 

  Hayley Shasteen
• 

  Business

  Latinx Employees Face Challenges Succeeding in the Life Sciences Industry

  BioSpace looks at the challenges faced by the Latinx community in the life sciences, from the origins of the challenges, to educational gain and the importance of mentorship.

  May 31, 2022

   · 

  13 min read

   · 

  Geoff Herman
• 

  BioForest

  Portland-based Nonprofit Takes Aim at Childhood Cancers

  Portland-based Children’s Cancer Therapy Development Institute is discovering more targeted drugs for childhood cancers and driving them into clinical development with industry partner Artisan Biopharma.

  May 31, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Policy

  WHO says “Window of Opportunity” Exists to Control Monkeypox Cases

  The WHO reports it’s too early to tell if the monkeypox outbreak could become a pandemic, but believe there is a window of opportunity to control the cases.

  May 31, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Biotech Bay

  With $600M in Funding, Ultima is Removing Cost Barriers to Genomic Research

  How much could a human genome cost? The answer is $100, according to newly launched biotech company Ultima Genomics, which received $600 million in backing.

  May 31, 2022

   · 

  3 min read

   · 

  Hayley Shasteen
• 

  Drug Development

  BioMarin Delays Hemophilia A Therapy Valoctocogene Roxaparvovec Filing as FDA Calls for More Data

  The U.S. FDA has requested some additional data from BioMarin Pharmaceuticals for the BLA it filed for the hemophilia A therapy valoctocogene roxaparvovec.

  May 31, 2022

   · 

  2 min read

   · 

  Paolo Besabella